uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted August 30, 2012

FDA Warns of Medical Claims Made For Numerous Chinese Herbal Products

On August 15, 2012, the FDA warned Dragon Herbs that promotional statements made on the company's website constitute drug claims for twenty herbal products, including CardioPro 2000, Cordyceps, Duanwood Reishi, Gynostemma, Ginseng and Astragalus Combination, Dang Gui and Gelatin, Sweet Relief, Remove Stagnation, Bupleurum and Dragon Bone, Amolo Tea, Activated Minor Bupleurum, Standardized Scute, Salacia, Shou Wu Formulations, Ant Essence Capsules, Ten Complete Supertonic, Super Adaptogen, Endocrine Health, Supreme Protector, and Super Pill. The FDA also warned that these products were misbranded due to inadequate directions for use.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at